PMC:7558333 / 371-523 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":11,"end":13},"obj":"Disease"},{"id":"T8","span":{"begin":17,"end":25},"obj":"Disease"},{"id":"T9","span":{"begin":63,"end":71},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"lassifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and a"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T4","span":{"begin":60,"end":62},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"}],"text":"lassifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and a"}

{"project":"LitCovid-PubTator","denotations":[{"id":"23","span":{"begin":37,"end":45},"obj":"Species"},{"id":"24","span":{"begin":72,"end":80},"obj":"Species"},{"id":"30","span":{"begin":127,"end":138},"obj":"Species"},{"id":"37","span":{"begin":17,"end":36},"obj":"Disease"},{"id":"38","span":{"begin":63,"end":71},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:9606"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Tax:9606"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Tax:746128"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:C000657245"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"lassifying IA in SARS-CoV-2-infected patients. (2) Methods: 45 COVID-19 patients were prospectively monitored twice weekly for Aspergillus markers and a"}